Hachimi-Idrissi S, Corne L, Ramet J
Paediatric Emergency Department, University Hospital of the Free University Brussels (AZ-VUB), Belgium.
Eur J Emerg Med. 1998 Jun;5(2):225-30.
Patients expected to develop life-threatening complications in acute meningococcal infections require early recognition and appropriate monitoring. Different prognostic scoring systems have been developed. Three of them, chosen according to their bedside availability, were compared with our clinical observations. Twenty consecutive cases of proven meningococcal infection were admitted to the paediatric intensive care unit (PICU) of the Free University of Brussels (AZ-VUB). Biological and clinical features required for prognostic scoring were evaluated as soon as possible after admission. Glasgow meningococcal sepsis prognostic score (GMSPS), Neisseria sepsis index (NESI) and Algren criteria were retrospectively calculated and evaluated for their prognostic significance. Neisseria meningitidis was cultured from blood and cerebrospinal fluid in 11 patients and from blood in only nine patients. The age of the patients was between 1 and 15 years (mean 4.1 years). All patients received the same therapy on admission. Four patients died with a multiorgan failure within 18 hours. The three scoring systems in these four patients predicted death. Overall, the GMSPS score, the NESI score and the Algren criteria predicted death in respectively 10, nine and five patients. Death was falsely predicted in six patients by the GMSPS score, in five patients by the NESI score and in one patient by the Algren criteria. The Algren criteria predicted the severity of the clinical process more accurately than did the GMSPS and NESI scores. However, such predictability should be cautiously used even when 100% mortality is predicted. It might be used in decision-making in regard to the following issues: patient transfer to tertiary centres and mode of transportation, monitoring of patients in intensive care units, early insertion of invasive cardiovascular monitoring catheters and consideration of new or even experimental therapy. However, one should be extremely cautious of taking any therapeutically or ethical decision on the basis of one or more of the described scoring system, since we showed the lack of precision concerning the outcome of paediatric patients with meningococcaemia.
预计在急性脑膜炎球菌感染中会出现危及生命并发症的患者需要早期识别和适当监测。已经开发了不同的预后评分系统。根据其床边可用性选择了其中三个,并与我们的临床观察结果进行了比较。连续20例经证实的脑膜炎球菌感染病例被收入布鲁塞尔自由大学(AZ-VUB)的儿科重症监护病房(PICU)。入院后尽快评估预后评分所需的生物学和临床特征。回顾性计算格拉斯哥脑膜炎球菌败血症预后评分(GMSPS)、奈瑟菌败血症指数(NESI)和阿尔格伦标准,并评估其预后意义。11例患者的血液和脑脊液中培养出脑膜炎奈瑟菌,仅9例患者的血液中培养出该菌。患者年龄在1至15岁之间(平均4.1岁)。所有患者入院时接受相同的治疗。4例患者在18小时内死于多器官功能衰竭。这4例患者的三个评分系统均预测了死亡。总体而言,GMSPS评分、NESI评分和阿尔格伦标准分别预测了10例、9例和5例患者死亡。GMSPS评分错误预测了6例患者死亡,NESI评分错误预测了5例患者死亡,阿尔格伦标准错误预测了1例患者死亡。阿尔格伦标准比GMSPS和NESI评分更准确地预测了临床过程的严重程度。然而,即使预测死亡率为100%,这种可预测性也应谨慎使用。它可用于以下问题的决策:患者转至三级中心及运输方式、重症监护病房患者的监测、早期插入有创心血管监测导管以及考虑新的甚至实验性治疗。然而,基于上述任何一种评分系统做出任何治疗或伦理决策时都应极其谨慎,因为我们发现儿童脑膜炎球菌血症患者的预后缺乏准确性。